- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (60)
- Timeline of Article Publication (2)
- Authors Evaluation (1)
- Article Quality Tracking (1)
- Reader Comments (1)
- Reference Citation Analysis (9)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3255)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 15, 2024 (publication date) through Oct 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nassar M, Chaudhuri A, Ghanim H, Dandona P. Glucagon-like peptide-1 receptor agonists as a possible intervention to delay the onset of type 1 diabetes: A new horizon. World J Diabetes 2024; 15(2): 133-136 [PMID: 38464377 DOI: 10.4239/wjd.v15.i2.133] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i2/133.htm |
| Number | Citing Articles |
| 1 |
Mahmoud Nassar, Omar Nassar, Hazem Abosheaishaa, Anoop Misra. Decreased risk of recurrent acute pancreatitis with semaglutide and tirzepatide in people with type 2 diabetes or obesity with a history of acute pancreatitis: A propensity matched global federated TriNetX database-based retrospective cohort study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2024; 18(9): 103116 doi: 10.1016/j.dsx.2024.103116
|